Vanda Pharmaceuticals Inc. Quarterly Operating Margin in % from Q4 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Vanda Pharmaceuticals Inc. quarterly/annual Operating Margin history and growth rate from Q4 2012 to Q2 2024.
  • Vanda Pharmaceuticals Inc. Operating Margin for the quarter ending June 30, 2024 was -17.8 %, a 540% decline year-over-year.
  • Vanda Pharmaceuticals Inc. annual Operating Margin for 2023 was -7.24 %, a 391% decline from 2022.
  • Vanda Pharmaceuticals Inc. annual Operating Margin for 2022 was 2.49 %, a 84.2% decline from 2021.
  • Vanda Pharmaceuticals Inc. annual Operating Margin for 2021 was 15.7 %, a 43% increase from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -17.8 -21.9 -540% Apr 1, 2024 Jun 30, 2024
Q1 2024 -14.2 -20.4 -328% Jan 1, 2024 Mar 31, 2024
Q4 2023 -7.24 -9.73 -391% Oct 1, 2023 Dec 31, 2023
Q3 2023 -0.11 -3.34 -103% Jul 1, 2023 Sep 30, 2023
Q2 2023 4.06 -1.75 -30.2% Apr 1, 2023 Jun 30, 2023
Q1 2023 6.23 -2.84 -31.3% Jan 1, 2023 Mar 31, 2023
Q4 2022 2.49 -13.2 -84.2% Oct 1, 2022 Dec 31, 2022
Q3 2022 3.23 -13.2 -80.3% Jul 1, 2022 Sep 30, 2022
Q2 2022 5.8 -10 -63.3% Apr 1, 2022 Jun 30, 2022
Q1 2022 9.07 -5.84 -39.2% Jan 1, 2022 Mar 31, 2022
Q4 2021 15.7 +4.72 +43% Oct 1, 2021 Dec 31, 2021
Q3 2021 16.4 +7.68 +88.2% Jul 1, 2021 Sep 30, 2021
Q2 2021 15.8 +5.83 +58.3% Apr 1, 2021 Jun 30, 2021
Q1 2021 14.9 +4.48 +42.9% Jan 1, 2021 Mar 31, 2021
Q4 2020 11 +0.94 +9.36% Oct 1, 2020 Dec 31, 2020
Q3 2020 8.71 -3.93 -31.1% Jul 1, 2020 Sep 30, 2020
Q2 2020 9.99 -1.1 -9.91% Apr 1, 2020 Jun 30, 2020
Q1 2020 10.4 +1.71 +19.6% Jan 1, 2020 Mar 31, 2020
Q4 2019 10 -1.22 -10.8% Oct 1, 2019 Dec 31, 2019
Q3 2019 12.6 +6.98 +123% Jul 1, 2019 Sep 30, 2019
Q2 2019 11.1 +11.5 Apr 1, 2019 Jun 30, 2019
Q1 2019 8.72 +12.6 Jan 1, 2019 Mar 31, 2019
Q4 2018 11.3 +21.5 Oct 1, 2018 Dec 31, 2018
Q3 2018 5.66 +15.4 Jul 1, 2018 Sep 30, 2018
Q2 2018 -0.41 +6.72 +94.2% Apr 1, 2018 Jun 30, 2018
Q1 2018 -3.83 +5.5 +59% Jan 1, 2018 Mar 31, 2018
Q4 2017 -10.2 +2.48 +19.5% Oct 1, 2017 Dec 31, 2017
Q3 2017 -9.69 +13.8 +58.8% Jul 1, 2017 Sep 30, 2017
Q2 2017 -7.13 +25.1 +77.8% Apr 1, 2017 Jun 30, 2017
Q1 2017 -9.32 +25.7 +73.4% Jan 1, 2017 Mar 31, 2017
Q4 2016 -12.7 +23.8 +65.2% Oct 1, 2016 Dec 31, 2016
Q3 2016 -23.5 -71 -149% Jul 1, 2016 Sep 30, 2016
Q2 2016 -32.2 -97.9 -149% Apr 1, 2016 Jun 30, 2016
Q1 2016 -35 -92.6 -161% Jan 1, 2016 Mar 31, 2016
Q4 2015 -36.6 -76.6 -191% Oct 1, 2015 Dec 31, 2015
Q3 2015 47.5 +179 Jul 1, 2015 Sep 30, 2015
Q2 2015 65.7 +229 Apr 1, 2015 Jun 30, 2015
Q1 2015 57.5 +181 Jan 1, 2015 Mar 31, 2015
Q4 2014 40 +103 Oct 1, 2014 Dec 31, 2014
Q3 2014 -132 -71.7 -119% Jul 1, 2014 Sep 30, 2014
Q2 2014 -164 -103 -170% Apr 1, 2014 Jun 30, 2014
Q1 2014 -124 -48.7 -65% Jan 1, 2014 Mar 31, 2014
Q4 2013 -62.6 +23.7 +27.4% Oct 1, 2013 Dec 31, 2013
Q3 2013 -60.1 Jul 1, 2013 Sep 30, 2013
Q2 2013 -60.8 Apr 1, 2013 Jun 30, 2013
Q1 2013 -75 Jan 1, 2013 Mar 31, 2013
Q4 2012 -86.2 Oct 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.